Bain Capital has entered into exclusive negotiations to acquire a controlling stake in Softway Medical, a leading health software publisher in France, aiming to accelerate its growth in the European market.

Information on the Target

Softway Medical is a leading health software publisher based in Fuveau, Bouches-du-Rhône, France. The company has shown significant growth, achieving a revenue of €150 million in 2024, with a target of €175 million for the current fiscal year. This growth is primarily driven by a robust organic growth rate of 15% to 20%. Softway Medical specializes in providing cloud-native solutions to a wide variety of healthcare institutions, including 1,300 hospitals and clinics, which collectively represent 40% of the market share, as well as 1,300 radiology centers, 700 health centers, and 400 laboratories. With over 1,200 employees, the company aims to expand its workforce by hiring an additional 150 to 200 individuals each year until 2030 as part of its eNov development plan.

Softway Medical has also adopted an aggressive growth strategy, having completed ten acquisitions to date. This includes three significant acquisitions made in 2024: SBIM in Belgium, EpiConcept, which specializes in epidemiology and health data, and a distribution agreement in Canada. Collectively, these initiatives have required investment totaling several tens of millions of euros, further solidifying Softway's position in the healthcare technology sector.

Industry Overview in France

The healthcare technology industry in France is experiencing a transformative phase, driven by the increasing demand for innovative and efficient solutions within the sector. France boasts a robust healthcare system that is continuously evolving, reflect